KDCA Conducts Quality Evaluation of Chronic Disease Diagnostic Testing System

[Asia Economy Reporter Chunhee Lee] The Korea Disease Control and Prevention Agency announced on the 8th that it will conduct a quality evaluation of diagnostic testing systems used by diagnostic testing institutions starting from the 26th to improve the quality of major diagnostic tests for chronic diseases.

The quality evaluation of diagnostic testing systems assesses the accuracy of six major chronic disease test items (▲glycated hemoglobin ▲creatinine ▲total cholesterol ▲triglycerides ▲HDL & LDL cholesterol) within the testing system composed of reagents, equipment, and calibration materials used by diagnostic testing institutions such as medical institutions and testing subcontractors. The quality evaluation analyzes and assesses the accuracy, precision, total error, linearity, and other factors of the diagnostic testing systems according to international standards set by the International Federation of Clinical Chemistry (IFCC) and the U.S. National Institutes of Health (NIH).

Institutions wishing to participate in the evaluation can download the application form from the diagnostic testing system quality evaluation project website and submit it to the Chronic Disease Prevention Division between the 16th and 20th.

To provide prior guidance on the diagnostic testing system quality evaluation, the KDCA will hold an online briefing session on the 16th in a non-face-to-face format. The briefing will cover the purpose, schedule, and methods of the quality evaluation, feature presentations by experts in the diagnostic testing field, and include a Q&A session with participants to discuss ways to improve the quality evaluation system.

Applications to participate in the briefing session can be submitted via email to the Chronic Disease Prevention Division from the 12th to the 14th.

Lee Seon-gyu, head of the Chronic Disease Prevention Division, stated, “Through the diagnostic testing system quality evaluation, we expect to enhance the effect of improving the quality of diagnostic tests by ensuring that diagnostic testing institutions use high-quality diagnostic testing systems.”